1 active not recruiting, 1 completed. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Active not recruiting 1, Completed 1 |
Follow Claudication, Intermittent: new trials by email Literature Review of Claudication, Intermittent trials Research Report on Claudication, Intermittent
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Effects of ATLAS Therapy on Nitric Oxide Bioavailability in Patients With Intermittent Claudication Tetrahydrobiopterin 10 mg/kg, Tetrahydrobiopterin 20 mg/kg, L-Ascorbate - Claudication, Intermittent, Peripheral Artery Disease | Phase 1 | Active not recruiting | Louis Messina | 10 | 2021-06-15 | 2026-04-15 |
| Arterial Imaging of Inflammation and Resolution After Endovascular Surgery 18F-FDG - Peripheral Arterial Disease, Claudication, Intermittent | Phase 1 | Completed | University of California, San Francisco | 9 | 2017-06-01 | 2020-11-30 |
Intermittent Claudication (2) · Peripheral Arterial Disease (2) · Arterial Occlusive Diseases (1) · Peripheral Vascular Diseases (1) · Vascular Calcification (1)
Arteriosclerosis (2) · Atherosclerosis (2) · Cardiovascular Diseases (2) · Pathological Conditions, Signs and Symptoms (2) · Signs and Symptoms (2) · Vascular Diseases (2) · Arterial Occlusive Diseases (1) · Calcinosis (1) · Calcium Metabolism Disorders (1) · Metabolic Diseases (1) · Nutritional and Metabolic Diseases (1) · Peripheral Vascular Diseases (1)
Arginine (1) · Fluorodeoxyglucose F18 (1) · sapropterin (1)
Louis Messina (1) · University of California, San Francisco (1)
United States (2)
Louis M Messina, MD (1) · Michael S Conte, M.D. (1) · Miguel H Pampaloni, M.D., PhD. (1)